Anbio Biotechnology (NNNN) vs Utah Medical Products, Inc. (UTMD)

Anbio Biotechnology and Utah Medical Products, Inc. are both Medical Instruments & Supplies companies. Anbio Biotechnology is the larger, with a market value of $516.6M against $202.4M — 2.6× the size. Across the 8 metrics below, Utah Medical Products, Inc. leads on 6 and Anbio Biotechnology on 2.

Valuation

Metric NNNN UTMD Medical Instruments & Supplies median
P/E — 21.68 30.28
P/S — 6.27 2.49
P/B n/m 1.86 2.34
Price to free cash flow n/m 19.78 23.49
EV/EBITDA n/m 10.99 14.87
EV/Sales n/m 3.87 2.75
Earnings yield — 4.61% 0.00%
Free cash flow yield 0.00% 5.06% 0.59%

Profitability

Metric NNNN UTMD Medical Instruments & Supplies median
Gross margin — 57.90% 53.60%
Operating margin — 28.43% 1.97%
Net margin — 29.04% 0.00%
Free cash flow margin 0.00% 31.70% 2.36%
Return on equity 0.00% 8.75% 0.00%
Return on assets 0.00% 8.55% 0.00%
Return on invested capital 0.00% 18.60% 0.13%

Growth

Metric NNNN UTMD Medical Instruments & Supplies median
Revenue growth (TTM) — (7.00%) 8.97%
EPS growth (last fiscal year) 150.00% (12.12%) 6.51%
Revenue growth, 5-year CAGR — (1.80%) 8.85%
Net income growth, 5-year CAGR — 0.89% 0.00%

Health

Metric NNNN UTMD Medical Instruments & Supplies median
Debt to equity 0.00 0.00 0.10
Current ratio 344.45 48.62 2.47
Net debt to EBITDA (2.06) (5.95) 0.97

Dividend

Metric NNNN UTMD Medical Instruments & Supplies median
Dividend yield — 1.74% 1.02%
Payout ratio — 0.38 0.27

Size

Metric NNNN UTMD Medical Instruments & Supplies median
Market cap 516.57m 202.40m 1.71b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack